Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) – a promising target for the immunotherapy of cancer

Overview of attention for article published in Frontiers in immunology, August 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 1 news outlet

twitter: 2 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 7 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 33,021 followers.

🔬 Une récente étude publiée par le Dr. Christa E. Muller à l'Université de Bonn en Allemagne, en collaboration avec le Dr. Jean Sévigny examine un candidat prometteur pour l'immunothérapie du cancer, l'héparine🌟 Pour en savoir plus: https://t.co/V6RHUDVSI

19 Oct 2023

Reply Repost Favourite

New Research: Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) – a promising target for the immunotherapy of cancer: Introduction Heparins, naturally occurring glycosaminoglycans, are widely used… #immunology ht

30 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.